Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
5(56%)
Results Posted
50%(2 trials)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_2
2
22%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(4)

Detailed Status

Recruiting5
Completed4

Development Timeline

Analytics

Development Status

Total Trials
9
Active
5
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (25.0%)
N/A6 (75.0%)

Trials by Status

completed444%
recruiting556%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9